The Mitochondrion-Targeted Antioxidants in Kidney Disease
Related Experiment Video
Updated: Dec 5, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Xinrui Li1, Liang Ma1, Ping Fu1
1Division of Nephrology and National Clinical Research Center for Geriatrics, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China.
Abstract:
Mitochondria are a potent source of cellular reactive oxygen species (ROS) and are vulnerable to oxidative damage. Mitochondria dysfunction could result in adenosine triphosphate (ATP) decrease and cell death. The kidney is an ATP-consuming organ, and the relationship between mitochondrial dysfunction and renal disease has been long noted. Mitochondrial targeting is a novel strategy for kidney diseases. At present, there are several ways to target mitochondria, such as the addition of a triphenylphosphonium cation, mitochondria-targeted peptides, and nanocarrier. There are also a variety of choices for the payload, such as nitroxides, quinone derivates, vitamins and so on. This review summarized the chemical and also clinical characteristics of various mitochondria- targeted antioxidants and focused on their application and perspectives in kidney diseases.
Insights
Mitochondria generate reactive oxygen species (ROS) and dysfunction can harm organs like the kidney. Targeting mitochondria with antioxidants offers a new strategy for treating kidney diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Nephrology
Background:
- Mitochondria are key sources of cellular reactive oxygen species (ROS), and their dysfunction can lead to decreased adenosine triphosphate (ATP) levels and cell death.
- Kidney diseases are often linked to mitochondrial dysfunction due to the kidney's high ATP consumption.
Purpose of the Study:
- To review chemical and clinical characteristics of mitochondria-targeted antioxidants.
- To focus on the application and future perspectives of these targeted antioxidants in kidney diseases.
Main Methods:
- Literature review of chemical and clinical data on mitochondria-targeted antioxidants.
- Analysis of various targeting strategies (e.g., triphenylphosphonium cation, peptides, nanocarriers).
- Examination of different antioxidant payloads (e.g., nitroxides, quinones, vitamins).
Main Results:
- Mitochondria-targeted antioxidants represent a promising therapeutic approach for kidney diseases.
- Various chemical strategies and payloads are available for mitochondrial targeting.
- Current research highlights the potential of these agents in preclinical and clinical settings.
Conclusions:
- Mitochondrial targeting offers a novel therapeutic avenue for kidney diseases.
- Further research is needed to fully elucidate the clinical efficacy and safety of these agents.
- Targeted antioxidant delivery to mitochondria holds significant promise for managing renal pathologies.
More Related Videos
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Mitochondria
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention